Interaction of Quinidine with Anticonvulsant Drugs
Overview
Authors
Affiliations
Drug-disposition studies of orally administered quinidine in four normal healthy volunteers indicated that phenobarbital and phenytoin reduced the half-life of quinidine by approximately 50 per cent (control, 3.0 to 6.1 hours, and with anticonvulsants, 1.6 to 2.6 hours). Alterations of similar magnitude in the apparent plasma clearance of quinidine after oral administration (control 20.0 to 32.0 liters per hour; with anticonvulsant 44.0 to 94.0 liters per hour) suggest that this effect is probably due to an increase in the rate of metabolism of quinidine, although decreased absorption cannot be entirely ruled out. In two index patients the concomitant use of anticonvulsant drugs resulted in inadequate blood levels of quinidine with standard dosages of that drug.
Therapeutic Drug Monitoring of Quinidine in Pediatric Patients with Genetic Variants.
Ferretti A, Simeoli R, Cairoli S, Pietrafusa N, Trivisano M, Vici C Pharmaceutics. 2022; 14(10).
PMID: 36297665 PMC: 9608568. DOI: 10.3390/pharmaceutics14102230.
Concurrent Quinidine and Phenobarbital in the Treatment of a Patient with 2 Mutations.
Passey C, Erramouspe J, Castellanos P, ODonnell E, Denton D Curr Ther Res Clin Exp. 2019; 90:106-108.
PMID: 31388363 PMC: 6677567. DOI: 10.1016/j.curtheres.2019.02.002.
Treatment Responsiveness in KCNT1-Related Epilepsy.
Fitzgerald M, Fiannacca M, Smith D, Gertler T, Gunning B, Syrbe S Neurotherapeutics. 2019; 16(3):848-857.
PMID: 31054119 PMC: 6694367. DOI: 10.1007/s13311-019-00739-y.
Almond L, Mukadam S, Gardner I, Okialda K, Wong S, Hatley O Drug Metab Dispos. 2016; 44(6):821-32.
PMID: 27026679 PMC: 4885489. DOI: 10.1124/dmd.115.066845.
Quinidine in the treatment of KCNT1-positive epilepsies.
Mikati M, Jiang Y, Carboni M, Shashi V, Petrovski S, Spillmann R Ann Neurol. 2015; 78(6):995-9.
PMID: 26369628 PMC: 4811613. DOI: 10.1002/ana.24520.